Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease

Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial

(2013) Alireza Esteghamati et al.   REGULATORY PEPTIDES

Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells

(2012) Kyosuke Kazama et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Serum Levels of Omentin in End-Stage Renal Disease Patients

(2012) Aytekin Alcelik et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Exploring metabolic dysfunction in chronic kidney disease

(2012) Adrian D Slee   Nutrition & Metabolism

Omentin as a novel biomarker of metabolic risk factors

(2012) Rei Shibata et al.   Diabetology & Metabolic Syndrome

Association of serum omentin-1 levels with coronary artery disease

(2011) Xia Zhong et al.   ACTA PHARMACOLOGICA SINICA

Vascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses

(2011) Hideyuki Yamawaki   BIOLOGICAL & PHARMACEUTICAL BULLETIN

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women

(2011) Teresa Auguet et al.   BMC Medical Genetics

Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes

(2011) Hye Yoo et al.   Cardiovascular Diabetology

Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression

(2011) H. Xie et al.   CARDIOVASCULAR RESEARCH

Diagnosis and Classification of Diabetes Mellitus

(2011)   DIABETES CARE

Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome

(2011) Rong Liu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease

(2011) H. O. El-Mesallamy et al.   DIABETIC MEDICINE

Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome

(2011) Ji-Hun Choi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men

(2011) Rei Shibata et al.   HYPERTENSION RESEARCH

Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction

(2011) José Maria Moreno-Navarrete et al.   Obesity

Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels

(2010) Hideyuki Yamawaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome

(2010) B. K. Tan et al.   DIABETES

Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes

(2010) Hong-Yan Pan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Inflammation, a Link between Obesity and Cardiovascular Disease

(2010) Zhaoxia Wang et al.   MEDIATORS OF INFLAMMATION

Circulating omentin concentration increases after weight loss

(2010) José Moreno-Navarrete et al.   Nutrition & Metabolism

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

(2010) Yusuf Yilmaz et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Visceral adipose tissue, adiponectin levels and insulin resistance are related to atherosclerosis as assessed by whole-body magnetic resonance angiography in an elderly population

(2008) T. Hansen et al.   ATHEROSCLEROSIS

Omentin-1, a Novel Adipokine, Is Decreased in Overweight Insulin-Resistant Women With Polycystic Ovary Syndrome: Ex Vivo and In Vivo Regulation of Omentin-1 by Insulin and Glucose

(2008) B. K. Tan et al.   DIABETES